<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1">
  <title>Amoxicillin - Medications - Offline Clinical Reference</title>
  <link rel="stylesheet" href="../style.css">
</head>
<body>
  <div class="topbar">
    <div class="topbar-inner">
      <span class="pill"><strong>Amoxicillin</strong></span>
      <span class="spacer"></span>
      <div class="nav-btns">
        <a class="btn small" href="../index.html">Home</a>
        <a class="btn small" href="../medications.html">Back to Medications</a>
      </div>
    </div>
  </div>

  <main class="wrap">
    <section class="section">
      <div class="kicker">Antibiotics / Antivirals</div>
      <h1>Amoxicillin</h1>

      <div class="content">
        <h3>Stocked on board</h3>
        <ul>
          <li>Amoxicillin 500mg Capsules</li>
        </ul>

        <div class="rule"></div>

        <h3>Adult dosing</h3>
        <ul>
          <li><strong>Acute otitis media (adult)</strong>
            <ul>
              <li>500 mg PO every 8 hours</li>
            </ul>
          </li>
          <li><strong>Acute bacterial sinusitis (adult; when antibiotics indicated)</strong>
            <ul>
              <li>500 mg PO every 8 hours OR 875 mg PO every 12 hours (if available locally)</li>
              <li>If using 500 mg capsules onboard: 500 mg PO every 8 hours</li>
            </ul>
          </li>
          <li><strong>Streptococcal pharyngitis (GAS) (adult; if treated)</strong>
            <ul>
              <li>500 mg PO every 12 hours for 10 days</li>
            </ul>
          </li>
          <li><strong>Community-acquired pneumonia (mild outpatient; when amoxicillin appropriate)</strong>
            <ul>
              <li>1 g PO every 8 hours (i.e., 2 x 500 mg capsules every 8 hours) for ~5–7 days (clinical response dependent)</li>
            </ul>
          </li>
          <li><strong>Endocarditis prophylaxis (only if specifically indicated by guideline/medical direction)</strong>
            <ul>
              <li>Dosing varies by guideline; follow local protocol/medical direction</li>
            </ul>
          </li>
        </ul>

        <div class="rule"></div>

        <h3>Indications</h3>
        <ul>
          <li>Susceptible bacterial infections (respiratory, ENT, skin/soft tissue, selected GU) where amoxicillin is appropriate</li>
          <li>Streptococcal pharyngitis (to prevent complications when treated)</li>
          <li>Selected CAP cases (when pathogen coverage is appropriate)</li>
        </ul>

        <div class="rule"></div>

        <h3>Contraindications / cautions</h3>
        <ul>
          <li>History of immediate hypersensitivity to penicillins (and caution with cephalosporin cross-reactivity depending on reaction)</li>
          <li>Suspected/confirmed infectious mononucleosis (rash risk with aminopenicillins)</li>
          <li>Dose adjustment required in significant renal impairment</li>
          <li>C. difficile-associated diarrhea risk: reassess if significant diarrhea develops during/after therapy</li>
          <li>Interactions/bleeding risk: INR may increase with warfarin (monitor if applicable)</li>
        </ul>

        <div class="rule"></div>

        <h3>Adverse effects</h3>
        <ul>
          <li>GI upset (nausea, diarrhea), rash</li>
          <li>Hypersensitivity reactions (urticaria → anaphylaxis)</li>
          <li>C. difficile-associated diarrhea (important but uncommon)</li>
        </ul>

        <div class="rule"></div>

        <h3>Preparation &amp; administration</h3>
        <ul>
          <li>Give with water; take at evenly spaced intervals</li>
          <li>If GI upset occurs, taking with food may improve tolerance (absorption considerations vary by product; prioritize adherence/tolerance onboard)</li>
          <li>Counsel: finish the prescribed course unless told otherwise; do not share leftover antibiotics</li>
        </ul>

        <div class="rule"></div>

        <h3>Monitoring</h3>
        <ul>
          <li>Clinical response within 48–72 hours (symptoms, fever, function)</li>
          <li>Allergy/rash; stop and seek help if signs of anaphylaxis</li>
          <li>Diarrhea severity (consider C. difficile if severe/persistent)</li>
          <li>If prolonged course or high-risk patient: consider renal function monitoring when feasible</li>
        </ul>

        <div class="rule"></div>

        <h3>At-sea considerations</h3>
        <ul>
          <li>Confirm indication and avoid antibiotics for likely viral/self-limited illness when possible (stewardship)</li>
          <li>If diagnostics are limited, reassess early non-response and consider alternate diagnosis or need for escalation/evac</li>
          <li>Document start date, dose, planned duration, and allergy status clearly</li>
        </ul>

        <div class="rule"></div>

        <h3>Online-only references</h3>
        <ul>
          <li>Health Canada product monograph (amoxicillin capsules): <a href="https://pdf.hres.ca/dpd_pm/00076457.PDF" target="_blank" rel="noopener">https://pdf.hres.ca/dpd_pm/00076457.PDF</a></li>
          <li>RxFiles (Acute Pharyngitis antibiotic summary – Canadian): <a href="https://rxfiles.ca/rxfiles/uploads/documents/ABX-Pharyngitis.pdf" target="_blank" rel="noopener">https://rxfiles.ca/rxfiles/uploads/documents/ABX-Pharyngitis.pdf</a></li>
        </ul>
      </div>

      <p class="foot">
        Verify dosing and indications against current clinical guidelines.
      </p>
    </section>
  </main>
</body>
</html>
